Structurally Modified Bioactive Peptide Inhibits SARS-CoV-2 Lentiviral Particles Expression

Khushwant S. Bhullar, Manal A. Nael, Khaled M. Elokely, Steven J. Drews, Jianping Wu

Open source

DOI
10.3390/pharmaceutics14102045
Published
09
Container
Pharmaceutics
Publisher
Not recorded
Open access
yes

Credibility signals

uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3390/pharmaceutics14102045,
  title = {Structurally Modified Bioactive Peptide Inhibits SARS-CoV-2 Lentiviral Particles Expression},
  author = {Khushwant S. Bhullar and Manal A. Nael and Khaled M. Elokely and Steven J. Drews and Jianping Wu},
  year = {2022},
  journal = {Pharmaceutics},
  doi = {10.3390/pharmaceutics14102045},
  url = {https://doi.org/10.3390/pharmaceutics14102045}
}

RIS

TY  - JOUR
TI  - Structurally Modified Bioactive Peptide Inhibits SARS-CoV-2 Lentiviral Particles Expression
AU  - Khushwant S. Bhullar
AU  - Manal A. Nael
AU  - Khaled M. Elokely
AU  - Steven J. Drews
AU  - Jianping Wu
PY  - 2022
JO  - Pharmaceutics
DO  - 10.3390/pharmaceutics14102045
UR  - https://doi.org/10.3390/pharmaceutics14102045
ER  - 

APA

Bhullar, K. S., Nael, M. A., Elokely, K. M., Drews, S. J., & Wu, J. (2022). Structurally Modified Bioactive Peptide Inhibits SARS-CoV-2 Lentiviral Particles Expression. Pharmaceutics. https://doi.org/10.3390/pharmaceutics14102045

Source records